RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Clinical trials for RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA trials appear
Sign up with your email to follow new studies for RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare brain tumor: targeted pill shows promise
Disease control Recruiting nowThis study tests an oral drug called MEKTOVI (binimetinib) in children and young adults (ages 1 to 39) with a rare brain tumor called adamantinomatous craniopharyngioma (ACP) that has come back or is growing. The drug works by blocking certain signals that help tumors grow. The m…
Matched conditions: RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Arthritis drug shows promise against rare childhood brain tumor
Disease control Recruiting nowThis study tests a drug called tocilizumab, already used for arthritis, in children and young adults (ages 1 to 39) with a rare brain tumor called adamantinomatous craniopharyngioma that has come back or is growing. The goal is to see if the drug can shrink the tumor or stop it f…
Matched conditions: RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 12, 2026 13:42 UTC